Table 4.
Relationship between this prognostic index and clinical characteristics
| Id | Age | Gender | Grade | Stage | T | M | N |
|---|---|---|---|---|---|---|---|
| FCN2 | − 0.904 (0.368) | 1.049 (0.302) | 1.059 (0.291) | − 1.288 (0.201) | − 1.279 (0.204) | − 0.979 (0.373) | − 1.162 (0.252) |
| ISG15 | 0.893 (0.374) | − 0.605 (0.547) | 4.947 (2.086e−06) | 0.137 (0.892) | 0.041 (0.967) | 1.528 (0.161) | 0.431 (0.667) |
| ANXA6 | − 0.887 (0.377) | 0.733 (0.467) | 6.299 (3.278e−09) | − 3.604 (4.279e−04) | − 2.352 (0.020) | − 0.671 (0.527) | − 1.595 (0.116) |
| PSMD11 | − 1.287 (0.201) | − 0.453 (0.652) | 7.169 (7.037e−08) | − 4.347 (2.882e−05) | − 2.412 (0.018) | 3.207 (0.009) | − 2.466 (0.016) |
| IGF1 | 0.167 (0.868) | 0.814 (0.421) | 2.729 (0.007) | − 3.378 (0.001) | − 2.948 (0.004) | − 0.898 (0.405) | − 1.024 (0.309) |
| CALR | − 0.256 (0.799) | 0.451 (0.654) | 4.962 (6.132e−05) | − 1.421 (0.159) | − 1.134 (0.259) | 2.436 (0.047) | − 0.188 (0.851) |
| TAP2 | 1.139 (0.257) | − 0.224 (0.823) | 7.519 (6.663e−12) | − 0.096 (0.924) | − 0.125 (0.901) | 6.731 (1.292e−07) | − 0.024 (0.981) |
| KCNH2 | 0.413 (0.681) | 0.445 (0.658) | 1.097 (0.282) | − 1.578 (0.117) | − 0.391 (0.696) | − 1.041 (0.345) | − 1.049 (0.298) |
| EDNRA | − 1.864 (0.064) | 0.58 (0.565) | 5.173 (1.908e−06) | − 4.125 (6.153e−05) | − 4.279 (3.448e−05) | − 1.494 (0.193) | − 1.791 (0.077) |
| AGTR1 | − 1.402 (0.164) | 0.621 (0.539) | − 0.81 (0.431) | 0.466 (0.643) | 0.536 (0.593) | 0.235 (0.820) | 0.878 (0.382) |
| CMTM8 | − 1.574 (0.118) | − 2.22 (0.029) | 0.663 (0.517) | − 1.224 (0.224) | − 1.191 (0.236) | − 1.956 (0.105) | − 1.652 (0.103) |
| RAC3 | − 0.403 (0.688) | 1.049 (0.301) | 2.818 (0.007) | − 0.553 (0.582) | 0.045 (0.964) | − 1.121 (0.313) | − 1.672 (0.100) |
| ANGPT1 | 0.012 (0.990) | 1.007 (0.322) | 1.145 (0.265) | − 2.163 (0.032) | − 1.868 (0.064) | − 0.425 (0.686) | − 0.822 (0.413) |
| PLXNB1 | 1.423 (0.158) | − 1.088 (0.282) | − 3.054 (0.008) | 3.497 (8.896e−04) | 2.954 (0.004) | 1.796 (0.112) | 3.924 (1.352e−04) |
| TRIM27 | 1.813 (0.072) | − 2.536 (0.013) | − 2.201 (0.043) | 2.488 (0.015) | 2.611 (0.011) | 3.608 (0.005) | 2.272 (0.026) |
| RBP7 | − 0.684 (0.495) | 1.126 (0.269) | 2.222 (0.028) | − 2.006 (0.047) | − 1.843 (0.068) | − 1.309 (0.247) | − 1.596 (0.118) |
| AHNAK | − 0.781 (0.436) | 1.479 (0.148) | 5.854 (2.277e−07) | − 3.813 (2.06e−04) | − 4.056 (8.06e−05) | 0.93 (0.385) | − 2.199 (0.031) |
| IL17RE | − 1.217 (0.225) | − 0.165 (0.870) | 3.215 (0.002) | − 1.686 (0.094) | − 1.347 (0.180) | − 0.755 (0.483) | − 1.667 (0.099) |
| riskScore | − 0.794 (0.429) | 2.243 (0.032) | 5.871 (7.764e−08) | − 5.649 (9.482e−08) | − 5.054 (1.442e−06) | − 2.051 (0.093) | − 3.08 (0.003) |